SCHEMBL10106925

SCHEMBL10106925

COc1ccc(/C(C)=N/OCc2ccc(F)cc2)cc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.49
LMNA P02545 2/20 0.49
PTBP1 P26599 1/20 0.49
PPARG P37231 1/20 0.47
PPARA Q07869 1/20 0.47
S1PR1 P21453 3/20 0.47
CA12 O43570 1/20 0.43
DUSP3 P51452 1/20 0.43
RECQL P46063 1/20 0.43
MPO P05164 1/20 0.41
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
TUBA1B P68363 1/20 0.41
TUBA4A P68366 1/20 0.41
TUBB4B P68371 1/20 0.41
TUBB3 Q13509 1/20 0.41
TUBB2A Q13885 1/20 0.41
TUBB8 Q3ZCM7 1/20 0.41
TUBA3E Q6PEY2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10107036 0.90 RECQL (0.43) SMN1; SMN2LMNAPTBP1PPARGPPARA
SCHEMBL10106877 0.88 GAA (0.46) SMN1; SMN2LMNAPPARGPPARAS1PR1
SCHEMBL10107226 0.88 MAOA (0.42) LMNAPPARGPPARAS1PR1RECQL
SCHEMBL15255539 0.87 NPC1 (0.48) SMN1; SMN2LMNAPPARGPPARAS1PR1
SCHEMBL10106852 0.86 PTPN7 (0.46) SMN1; SMN2LMNAPTBP1PPARGPPARA
SCHEMBL10107282 0.85 MAPT (0.49) SMN1; SMN2LMNAPPARGPPARAS1PR1
SCHEMBL10106822 0.85 TUBB4A (0.42) SMN1; SMN2LMNAPPARGPPARAS1PR1
SCHEMBL10102038 0.84 SMN1; SMN2 (0.51) SMN1; SMN2LMNAPTBP1PPARGPPARA
SCHEMBL10107287 0.84 MAOB (0.43) SMN1; SMN2LMNAPTBP1PPARGPPARA
SCHEMBL10107294 0.84 NPC1 (0.62) SMN1; SMN2S1PR1RECQLTUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8536157-B2 Non-steroidal compounds THE UNIVERSITY OF MELBOURNE (AU) 2013-09-17 US disclosed
US-8536157-B2 Non-steroidal compounds THE UNIVERSITY OF MELBOURNE (AU) 2013-09-17 US disclosed
US-20120046255-A1 NON-STEROIDAL COMPOUNDS THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE (AU) 2012-02-23 US disclosed
WO-2008124878-A1 NON-STEROIDAL COMPOUNDS CRYPTOPHARMA PTY LTD (AU) 2008-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046255-A1 NON-STEROIDAL COMPOUNDS PTGES2, PTGES, PTGES3 SMN1; SMN2 3060/4885LMNA 2636/4885PTBP1 2831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.